Nanjing Libravo Pharmaceutical Co., Ltd. – FDA Inspection, Jul 17, 2026

Record Details

This FDA Inspection record concerns Nanjing Libravo Pharmaceutical Co., Ltd., with an inspection on July 17, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Nanjing Libravo Pharmaceutical Co., Ltd.
Inspection Date: July 17, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Truong X. Nguyen (FDA Associated Person)

View Company Profile

ID · 17f2a4b9-6f56-48db-bf9b-b215040a03a0

Inspection Facts

Inspection number: 1328102
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nanjing Libravo Pharmaceutical Co., Ltd.

FDA Inspection

Nanjing Libravo Pharmaceutical Co., Ltd.July 17, 2026

Nanjing Libravo Pharmaceutical Co., Ltd. – FDA Inspection, Jul 17, 2026

Record Details

This FDA Inspection record concerns Nanjing Libravo Pharmaceutical Co., Ltd., with an inspection on July 17, 2026, issued by the Office of Inspections and Investigations, covering human drugs.